In utero, childhood, and adolescence tobacco smoke exposure, physical activity, and chronic kidney disease incidence in adulthood: evidence from a large prospective cohort study
- PMID: 39523304
- PMCID: PMC11552372
- DOI: 10.1186/s12916-024-03745-w
In utero, childhood, and adolescence tobacco smoke exposure, physical activity, and chronic kidney disease incidence in adulthood: evidence from a large prospective cohort study
Abstract
Background: The adverse effects of early-life tobacco smoke exposure on chronic kidney disease (CKD) risk remain unclear. This study aimed to investigate the associations of early-life tobacco smoke exposure with CKD incidence in adulthood, and further explore the modification effects of physical activity (PA).
Methods: A total of 352,883 participants were included from the UK Biobank. The information on early-life tobacco smoke exposure was assessed by employing in utero tobacco smoke exposure and age of smoking initiation. Weekly moderate-to-vigorous physical activity (MVPA) was calculated for each individual. Cox proportional hazard regression was fitted to estimate the hazard ratio (HR) and 95% confidence interval (CI) of CKD risk, and to investigate the modification effects of MVPA.
Results: CKD incidence significantly increased in participants with in utero tobacco smoke exposure (HR: 1.08, 95% CI: 1.04, 1.12). Compared with never-smokers, we found a monotonic increase in the risk of CKD with smoking initiation across adulthood (HR: 1.21, 95% CI: 1.16, 1.27), adolescence (HR: 1.29, 95% CI: 1.24, 1.35), and childhood (HR: 1.34, 95% CI: 1.25, 1.43) (P trend < 0.001). Additionally, we identified joint cumulative effects of MVPA and early-life tobacco smoke exposure on incident CKD. Compared with never-smokers with recommended MVPA, prenatal or childhood tobacco smokers without recommended MVPA had the highest CKD risk, and the HRs (95% CIs) were 1.17 (1.10, 1.24) and 1.51 (1.36, 1.68), respectively.
Conclusions: Early-life tobacco smoke exposure may contribute to CKD incidence in adulthood, and the observed associations could be modified by MVPA. These findings provide important information on CKD prevention in the participant's early life while urging a more rapid and powerful need for tobacco control among pregnant couples, children, and adolescents.
Keywords: Chronic kidney disease; Early-life tobacco smoke exposure; Physical activity.
© 2024. The Author(s).
Conflict of interest statement
Figures


Similar articles
-
In Utero/Childhood/ Adolescence Exposure to Tobacco Smoke and Elderly-Onset Cataract: A Large Prospective Cohort Study.Transl Vis Sci Technol. 2024 Nov 4;13(11):21. doi: 10.1167/tvst.13.11.21. Transl Vis Sci Technol. 2024. PMID: 39556083 Free PMC article.
-
Early-life tobacco smoke exposure, genetic susceptibility and the risk of type 2 diabetes in adulthood: A large prospective cohort study.Sci Total Environ. 2023 Oct 1;893:164698. doi: 10.1016/j.scitotenv.2023.164698. Epub 2023 Jun 9. Sci Total Environ. 2023. PMID: 37302600
-
In Utero and Childhood/Adolescence Exposure to Tobacco Smoke, Genetic Risk, and Lung Cancer Incidence and Mortality in Adulthood.Am J Respir Crit Care Med. 2023 Jan 15;207(2):173-182. doi: 10.1164/rccm.202112-2758OC. Am J Respir Crit Care Med. 2023. PMID: 35943859
-
The Effects of Tobacco Smoking, and Prenatal Tobacco Smoke Exposure, on Risk of Schizophrenia: A Systematic Review and Meta-Analysis.Nicotine Tob Res. 2020 Jan 27;22(1):3-10. doi: 10.1093/ntr/nty160. Nicotine Tob Res. 2020. PMID: 30102383
-
Tobacco, e-cigarettes, and child health.Curr Opin Pediatr. 2017 Apr;29(2):225-230. doi: 10.1097/MOP.0000000000000456. Curr Opin Pediatr. 2017. PMID: 28059903 Free PMC article. Review.
Cited by
-
Epidemiological trends and risk factors of CKD-T1DM in children and adolescents across 204 countries and territories (1990-2021).Front Endocrinol (Lausanne). 2025 Mar 26;16:1551467. doi: 10.3389/fendo.2025.1551467. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40206600 Free PMC article.
References
-
- Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY, Yang CW. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260–72. - PubMed
-
- Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. Lancet. 2017;389(10075):1238–52. - PubMed
-
- Jager KJ, Kovesdy C, Langham R, Rosenberg M, Jha V, Zoccali C. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int. 2019;96(5):1048–50. - PubMed
-
- Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, Kurella Tamura M, Feldman HI. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63(5):713–35. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical